Verona Pharma PLC ADR (VRNA) — Long-term Investment Intensity
Verona Pharma PLC ADR (VRNA) has a Long-term Investment Intensity of 2.6% as of June 2025. Long-term investments of $15.00 Million represent 2.6% of total assets of $572.87 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check VRNA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Verona Pharma PLC ADR Long-term Investment Intensity (2021–2024)
This chart shows how Verona Pharma PLC ADR's Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the intensity stands at 2.6%, reflecting long-term investments of $15.00 Million against total assets of $572.87 Million USD. Explore VRNA debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Verona Pharma PLC ADR (2021–2024)
The table below presents the year-by-year Long-term Investment Intensity for Verona Pharma PLC ADR from 2021 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Verona Pharma PLC ADR market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 3.2% | $15.00 Million | $474.24 Million | ▼ -1.7 pp |
| 2023 | 4.9% | $15.00 Million | $308.12 Million | ▼ -0.9 pp |
| 2022 | 5.8% | $15.00 Million | $259.47 Million | ▼ -2.3 pp |
| 2021 | 8.0% | $15.00 Million | $186.59 Million | — |